-
1
-
-
33748301260
-
Global challenges in liver disease
-
Williams R. Global challenges in liver disease. Hepatology 44 3 (2006) 521-526
-
(2006)
Hepatology
, vol.44
, Issue.3
, pp. 521-526
-
-
Williams, R.1
-
2
-
-
0642374132
-
Resistance of HBV to adefovir dipivoxil: a case for combination antiviral therapy?
-
Aloman C., and Wands J.R. Resistance of HBV to adefovir dipivoxil: a case for combination antiviral therapy?. Hepatology 38 6 (2003) 1584-1587
-
(2003)
Hepatology
, vol.38
, Issue.6
, pp. 1584-1587
-
-
Aloman, C.1
Wands, J.R.2
-
3
-
-
67349143378
-
New perspectives for hepatitis B vaccines and immunization
-
Rapicetta M., D'Ugo E., Argentini C., Catone S., Canitano A., Giuseppetti R., et al. New perspectives for hepatitis B vaccines and immunization. Vaccine (2009)
-
(2009)
Vaccine
-
-
Rapicetta, M.1
D'Ugo, E.2
Argentini, C.3
Catone, S.4
Canitano, A.5
Giuseppetti, R.6
-
4
-
-
0034494840
-
Meta-analysis of published clinical trials of a ribosomal vaccine (ribomunyl ((r))) in prevention of respiratory infections
-
Boyle P., Bellanti J.A., and Robertson C. Meta-analysis of published clinical trials of a ribosomal vaccine (ribomunyl ((r))) in prevention of respiratory infections. Biodrugs 14 6 (2000) 389-408
-
(2000)
Biodrugs
, vol.14
, Issue.6
, pp. 389-408
-
-
Boyle, P.1
Bellanti, J.A.2
Robertson, C.3
-
5
-
-
24944567410
-
Augmented humoral and cellular immune responses to hepatitis B DNA vaccine adsorbed onto cationic microparticles
-
He X., Jiang L., Wang F., Xiao Z., Li J., Liu L.S., et al. Augmented humoral and cellular immune responses to hepatitis B DNA vaccine adsorbed onto cationic microparticles. J Control Release 107 2 (2005) 357-372
-
(2005)
J Control Release
, vol.107
, Issue.2
, pp. 357-372
-
-
He, X.1
Jiang, L.2
Wang, F.3
Xiao, Z.4
Li, J.5
Liu, L.S.6
-
6
-
-
6344272747
-
Cellular immune responses to the hepatitis B virus polymerase
-
Mizukoshi E., Sidney J., Livingston B., Ghany M., Hoofnagle J.H., Sette A., et al. Cellular immune responses to the hepatitis B virus polymerase. J Immunol 173 9 (2004) 5863-5871
-
(2004)
J Immunol
, vol.173
, Issue.9
, pp. 5863-5871
-
-
Mizukoshi, E.1
Sidney, J.2
Livingston, B.3
Ghany, M.4
Hoofnagle, J.H.5
Sette, A.6
-
7
-
-
0035925668
-
Immunotherapy of chronic hepatitis B by anti-HBV vaccine: from present to future
-
Michel M.L., Pol S., Brechot C., and Tiollais P. Immunotherapy of chronic hepatitis B by anti-HBV vaccine: from present to future. Vaccine 19 17-19 (2001) 2395-2399
-
(2001)
Vaccine
, vol.19
, Issue.17-19
, pp. 2395-2399
-
-
Michel, M.L.1
Pol, S.2
Brechot, C.3
Tiollais, P.4
-
8
-
-
0032546352
-
Dendritic cells and the control of immunity
-
Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 6673 (1998) 245-252
-
(1998)
Nature
, vol.392
, Issue.6673
, pp. 245-252
-
-
Banchereau, J.1
Steinman, R.M.2
-
10
-
-
0024353079
-
TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties
-
Mosmann T.R., and Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7 (1989) 145-173
-
(1989)
Annu Rev Immunol
, vol.7
, pp. 145-173
-
-
Mosmann, T.R.1
Coffman, R.L.2
-
11
-
-
0035031781
-
Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity
-
Stubbs A.C., Martin K.S., Coeshott C., Skaates S.V., Kuritzkes D.R., Bellgrau D., et al. Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity. Nat Med 7 5 (2001) 625-629
-
(2001)
Nat Med
, vol.7
, Issue.5
, pp. 625-629
-
-
Stubbs, A.C.1
Martin, K.S.2
Coeshott, C.3
Skaates, S.V.4
Kuritzkes, D.R.5
Bellgrau, D.6
-
12
-
-
17844404559
-
Yeasts encoding tumour antigens in cancer immunotherapy
-
Franzusoff A., Duke R.C., King T.H., Lu Y., and Rodell T.C. Yeasts encoding tumour antigens in cancer immunotherapy. Expert Opin Biol Ther 5 4 (2005) 565-575
-
(2005)
Expert Opin Biol Ther
, vol.5
, Issue.4
, pp. 565-575
-
-
Franzusoff, A.1
Duke, R.C.2
King, T.H.3
Lu, Y.4
Rodell, T.C.5
-
13
-
-
48249091314
-
Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses
-
Wansley E.K., Chakraborty M., Hance K.W., Bernstein M.B., Boehm A.L., Guo Z., et al. Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses. Clin Cancer Res 14 13 (2008) 4316-4325
-
(2008)
Clin Cancer Res
, vol.14
, Issue.13
, pp. 4316-4325
-
-
Wansley, E.K.1
Chakraborty, M.2
Hance, K.W.3
Bernstein, M.B.4
Boehm, A.L.5
Guo, Z.6
-
14
-
-
37849035624
-
Recombinant Saccharomyces cerevisiae (yeast-CEA) as a potent activator of murine dendritic cells
-
Bernstein M.B., Chakraborty M., Wansley E.K., Guo Z., Franzusoff A., Mostbock S., et al. Recombinant Saccharomyces cerevisiae (yeast-CEA) as a potent activator of murine dendritic cells. Vaccine 26 4 (2008) 509-521
-
(2008)
Vaccine
, vol.26
, Issue.4
, pp. 509-521
-
-
Bernstein, M.B.1
Chakraborty, M.2
Wansley, E.K.3
Guo, Z.4
Franzusoff, A.5
Mostbock, S.6
-
15
-
-
0036079796
-
Recombinant yeast as a vaccine vector for the induction of cytotoxic T-lymphocyte responses
-
Stubbs A.C., and Wilson C.C. Recombinant yeast as a vaccine vector for the induction of cytotoxic T-lymphocyte responses. Curr Opin Mol Ther 4 1 (2002) 35-40
-
(2002)
Curr Opin Mol Ther
, vol.4
, Issue.1
, pp. 35-40
-
-
Stubbs, A.C.1
Wilson, C.C.2
-
16
-
-
33846088350
-
Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins
-
Haller A.A., Lauer G.M., King T.H., Kemmler C., Fiolkoski V., Lu Y., et al. Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins. Vaccine 25 8 (2007) 1452-1463
-
(2007)
Vaccine
, vol.25
, Issue.8
, pp. 1452-1463
-
-
Haller, A.A.1
Lauer, G.M.2
King, T.H.3
Kemmler, C.4
Fiolkoski, V.5
Lu, Y.6
-
17
-
-
27644574423
-
New yeast expression platforms based on methylotrophic Hansenula polymorpha and Pichia pastoris and on dimorphic Arxula adeninivorans and Yarrowia lipolytica-a comparison
-
Gellissen G., Kunze G., Gaillardin C., Cregg J.M., Berardi E., Veenhuis M., et al. New yeast expression platforms based on methylotrophic Hansenula polymorpha and Pichia pastoris and on dimorphic Arxula adeninivorans and Yarrowia lipolytica-a comparison. FEMS Yeast Res 5 11 (2005) 1079-1096
-
(2005)
FEMS Yeast Res
, vol.5
, Issue.11
, pp. 1079-1096
-
-
Gellissen, G.1
Kunze, G.2
Gaillardin, C.3
Cregg, J.M.4
Berardi, E.5
Veenhuis, M.6
-
18
-
-
47149115664
-
Analysis and characterization of hepatitis B vaccine particles synthesized from Hansenula polymorpha
-
Seo H.S., Park J.S., Han K.Y., Bae K.D., Ahn S.J., Kang H.A., et al. Analysis and characterization of hepatitis B vaccine particles synthesized from Hansenula polymorpha. Vaccine 26 33 (2008) 4138-4144
-
(2008)
Vaccine
, vol.26
, Issue.33
, pp. 4138-4144
-
-
Seo, H.S.1
Park, J.S.2
Han, K.Y.3
Bae, K.D.4
Ahn, S.J.5
Kang, H.A.6
-
19
-
-
70649092199
-
Expression of ORF2 protein of HEV genotype IV in Hansenula polymorpha
-
Su C.X., Gu M.R., Zhang P., Jin Z.J., Meng F.H., Chen E.J., et al. Expression of ORF2 protein of HEV genotype IV in Hansenula polymorpha. Sheng Wu Gong Cheng Xue Bao 23 1 (2007) 73-78
-
(2007)
Sheng Wu Gong Cheng Xue Bao
, vol.23
, Issue.1
, pp. 73-78
-
-
Su, C.X.1
Gu, M.R.2
Zhang, P.3
Jin, Z.J.4
Meng, F.H.5
Chen, E.J.6
-
20
-
-
0030903829
-
Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha) composition, structure and immunogenicity
-
Diminsky D., Schirmbeck R., Reimann J., and Barenholz Y. Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha) composition, structure and immunogenicity. Vaccine 15 6-7 (1997) 637-647
-
(1997)
Vaccine
, vol.15
, Issue.6-7
, pp. 637-647
-
-
Diminsky, D.1
Schirmbeck, R.2
Reimann, J.3
Barenholz, Y.4
-
21
-
-
0027935971
-
CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity
-
Lichtenfels R., Biddison W.E., Schulz H., Vogt A.B., and Martin R. CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J Immunol Methods 172 2 (1994) 227-239
-
(1994)
J Immunol Methods
, vol.172
, Issue.2
, pp. 227-239
-
-
Lichtenfels, R.1
Biddison, W.E.2
Schulz, H.3
Vogt, A.B.4
Martin, R.5
-
22
-
-
0035919599
-
Therapeutic efficacy of hepatitis B surface antigen-antibodies-recombinant DNA composite in HBsAg transgenic mice
-
Zheng B.J., Ng M.H., He L.F., Yao X., Chan K.W., Yuen K.Y., et al. Therapeutic efficacy of hepatitis B surface antigen-antibodies-recombinant DNA composite in HBsAg transgenic mice. Vaccine 19 30 (2001) 4219-4225
-
(2001)
Vaccine
, vol.19
, Issue.30
, pp. 4219-4225
-
-
Zheng, B.J.1
Ng, M.H.2
He, L.F.3
Yao, X.4
Chan, K.W.5
Yuen, K.Y.6
-
23
-
-
0036518287
-
Mouse and human dendritic cell subtypes
-
Shortman K., and Liu Y.J. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2 3 (2002) 151-161
-
(2002)
Nat Rev Immunol
, vol.2
, Issue.3
, pp. 151-161
-
-
Shortman, K.1
Liu, Y.J.2
-
24
-
-
2142827027
-
The primary study on the anti-HBV effect of whole recombinant yeast
-
Zeng Y., Cai D.C., Peng M.L., and Ren H. The primary study on the anti-HBV effect of whole recombinant yeast. Zhonghua Gan Zang Bing Za Zhi 11 12 (2003) 728-730
-
(2003)
Zhonghua Gan Zang Bing Za Zhi
, vol.11
, Issue.12
, pp. 728-730
-
-
Zeng, Y.1
Cai, D.C.2
Peng, M.L.3
Ren, H.4
-
25
-
-
0029878805
-
Yeast expressing hepatitis B virus surface antigen determinants on its surface: implications for a possible oral vaccine
-
Schreuder M.P., Deen C., Boersma W.J., Pouwels P.H., and Klis F.M. Yeast expressing hepatitis B virus surface antigen determinants on its surface: implications for a possible oral vaccine. Vaccine 14 5 (1996) 383-388
-
(1996)
Vaccine
, vol.14
, Issue.5
, pp. 383-388
-
-
Schreuder, M.P.1
Deen, C.2
Boersma, W.J.3
Pouwels, P.H.4
Klis, F.M.5
-
26
-
-
33744808242
-
The immune response during hepatitis B virus infection
-
Bertoletti A., and Gehring A.J. The immune response during hepatitis B virus infection. J Gen Virol 87 Pt 6 (2006) 1439-1449
-
(2006)
J Gen Virol
, vol.87
, Issue.PART 6
, pp. 1439-1449
-
-
Bertoletti, A.1
Gehring, A.J.2
|